Genome Biologics
PrivateLast Round
VC Round
Dec 20, 2021
Total Funding Raised
$3.01M
Company Overview
Genome Biologics is a biotechnology company that provides human cardiac organoid services for drug discovery, cardiac safety pharmacology, and disease modeling.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Clinical Trials, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genome Biologics Comparables
Compare Genome Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HeartBeat.bio AG | 90% | |
| Ncardia | 83% | |
| Dynomics | 82% | |
Genome Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 20, 2021 | ||||
| Grant | Sep 1, 2018 |
Genome Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| European Innovation Council Fund | VC Round |
| Johnson & Johnson Innovation - JLABS | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 1527% MoM.
- Jun 1, 2025
Monthly visitors increased 223% MoM.
Genome Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genome Biologics's valuation, stock price, and market status.